Allergy Delabeling in Antibiotic Stewardship - Intervention

Clinical trial NCT07133074 · RECRUITING

Trial details

NCT number: NCT07133074
Sponsor: Abramson Cancer Center at Penn Medicine
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Beta Lactam Allergy Hematologic Malignancy

Start date: 2026-04-20
Primary completion: 2028-11-01
Enrollment: 3800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.